Robert J Gould
CIK 1577034 · Interim President & CEO · last filed 2026-02-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.62M
Companies
3
Total Filings
42
Lifetime Open-Market Net
-$16.34M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FULC | Director | 469,864 | $3.45 | $1.62M | -$5.10M | 28 | 2026-02-04 |
| Turnstone Biologics Corp. (TSBX) Delisted | Director | — | $0.35 | — | $0 | 1 | 2024-07-02 |
| Epizyme, Inc. (EPZM) Delisted | President & CEO | 0 | $1.47 | $0 | -$11.24M | 13 | 2015-12-31 |
Recent Filings · Page 5 of 5
42 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-01-30 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-01-06 | Epizyme, Inc. (EPZM) Delisted | Mixed | — | -$594.7K | EDGAR |
Showing 41–42 of 42
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.